Gantacurium | 758669-50-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: Gantacurium
• 英文别名: 4-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate
• CAS: 758669-50-0
• 化学式: C53H69ClN2O14+2
• 分子量: 993.6
• InChiKey: ZQLDXCSTJFLRPY-RWBXLJKRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.3
• 重原子数：
  70
• 可旋转键数：
  25
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  145
• 氢给体数：
  0
• 氢受体数：
  14

ADMET

代谢

药代动力学参数与血浆半胱氨酸的现场快速灭活一致。

The pharmacokinetic parameters are consistent with in situ rapid inactivation by plasma cysteine.

来源:DrugBank

反应信息

• 作为反应物：
  描述：

  Gantacurium 、 Chlorofumarate 、 、 、 三乙胺 以 乙腈 为溶剂， 生成 、 chlorofumaric acid
  参考文献：
  名称：

  Reversible nondepolarizing neuromuscular blockade agents and methods for their use

  摘要：

  该发明提供了一种非去极化型神经肌肉阻滞剂，几乎没有循环影响。该发明的化合物包括富马酸、马来酸、琥珀酸和乙炔二羧酸的双(异喹啉基)醇二酯；适用于这些化合物的静脉注射制剂作为麻醉手术的辅助治疗，以及这些化合物的制备方法。该发明的化合物可以产生短或中等持续时间的神经肌肉阻滞，对于各种化合物，可以通过给予硫醇化合物（如L-半胱氨酸、D-半胱氨酸或谷胱甘肽）来逆转。对于该发明的各种化合物，神经肌肉阻滞效果可以快速、有效地逆转，而且没有明显的副作用。

  公开号：

  US08592451B2

文献信息

• REVERSIBLE NONDEPOLARIZING NEUROMUSCULAR BLOCKADE AGENTS AND METHODS FOR THEIR USE
  申请人：Savarese John J.

  公开号：US20120095041A1

  公开（公告）日：2012-04-19

  The invention provides neuromuscular blockade agents of the non-depolarizing type with few if any circulatory effects. Compounds of the invention include bis(isoquinolylalkanol) diesters of fumaric, maleic, succinic, and acetylenedicarboxylic acids; compositions suitable for parenteral administration of these compounds as a surgical adjunct to anesthesia, and methods of preparation of the compounds. Compounds of the invention can produce neuromuscular blockade of short or intermediate duration, which for various compounds can be reversed by administration of a thiol compound such as L-cysteine, D-cysteine or glutathione. For various compounds of the invention, the neuromuscular blockade effect can be reversed quickly, efficiently, and without notable side-effects.

  本发明提供了一种非去极化型的神经肌肉阻滞剂，其循环效应很少或没有。该发明的化合物包括富马酸、马来酸、琥珀酸和乙炔二羧酸的双(异喹啉基烷醇)二酯；适用于这些化合物的静脉注射制剂作为麻醉手术辅助剂，以及制备这些化合物的方法。该发明的化合物可以产生短期或中等期的神经肌肉阻滞效果，对于各种化合物，可以通过给予巯基化合物如L-半胱氨酸、D-半胱氨酸或谷胱甘肽来逆转。对于该发明的各种化合物，神经肌肉阻滞效果可以快速、有效地逆转，且没有明显的副作用。
• NOVEL COLORED SOLUTIONS OF INJECTABLE DRUGS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
  申请人：Winch Peter D.

  公开号：US20090156562A1

  公开（公告）日：2009-06-18

  The invention is directed to pharmaceutical compositions comprising colored solutions, colored emulsions, or colored powders of injectable pharmaceuticals wherein said pharmaceuticals are selected from the group consisting of muscle relaxants, hypnotics, induction agents, and anticholinergics. The formulations of the present invention may all be colored using fluorescein. Different colors may be achieved by either varying the concentration of fluorescein, or by combining fluorescein with another dye. The invention is also directed to methods involving the use of said pharmaceutical compositions.
• Reversible nondepolarizing neuromuscular blockade agents and methods for their use
  申请人：Savarese John J.

  公开号：US08592451B2

  公开（公告）日：2013-11-26

  The invention provides neuromuscular blockade agents of the non-depolarizing type with few if any circulatory effects. Compounds of the invention include bis(isoquinolylalkanol) diesters of fumaric, maleic, succinic, and acetylenedicarboxylic acids; compositions suitable for parenteral administration of these compounds as a surgical adjunct to anesthesia, and methods of preparation of the compounds. Compounds of the invention can produce neuromuscular blockade of short or intermediate duration, which for various compounds can be reversed by administration of a thiol compound such as L-cysteine, D-cysteine or glutathione. For various compounds of the invention, the neuromuscular blockade effect can be reversed quickly, efficiently, and without notable side-effects.

  该发明提供了一种非去极化型神经肌肉阻滞剂，几乎没有循环影响。该发明的化合物包括富马酸、马来酸、琥珀酸和乙炔二羧酸的双(异喹啉基)醇二酯；适用于这些化合物的静脉注射制剂作为麻醉手术的辅助治疗，以及这些化合物的制备方法。该发明的化合物可以产生短或中等持续时间的神经肌肉阻滞，对于各种化合物，可以通过给予硫醇化合物（如L-半胱氨酸、D-半胱氨酸或谷胱甘肽）来逆转。对于该发明的各种化合物，神经肌肉阻滞效果可以快速、有效地逆转，而且没有明显的副作用。